Advances in the analysis of non-allowed pharmacologically active substances in cosmetic products

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 4, 2011, Pages 842-847

  Pellegrini, Manuela ^a   Marchei, Emilia ^a   Pacifici, Roberta ^a   Rotolo, Maria Concetta ^a   Pichini, Simona ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cosmetics; Gas chromatography; Liquid chromatography; Mass spectrometry; Non allowed pharmacologically active substances

Indexed keywords

AMINOPHYLLINE; ANESTHETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; BOTULINUM TOXIN; COSMETIC; GLUCOCORTICOID; RETINOIC ACID;

COSMETIC INDUSTRY; ENVIRONMENTAL TEMPERATURE; HUMAN; LIQUID CHROMATOGRAPHY; MARKETING; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; PRODUCT SAFETY; QUALITY CONTROL; REVIEW; TOXICITY TESTING; ULTRAVIOLET SPECTROPHOTOMETRY;

CHEMISTRY TECHNIQUES, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; COSMETICS; EUROPE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE;

EID: 79955471123     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.043     Document Type: Review

References (17)

1. WHO, Fact sheet 275, 2003.
2. Federal Food, Drug, and Cosmetic Act, chapter II, section 201.
3. Colipa: Cosmetics Directive 76/768/EEC, Explanatory Brochure, The European Cosmetic Toiletry and Perfumery Association, January 2004.
4. Pauwels M., Rogiers V. Human health safety evaluation of cosmetics in EU: a legally imposed challenge to science. Toxicol. Appl. Pharmacol. 2010, 243:260-274.
5. Newburger A.E. Cosmeceuticals: myths and misconceptions. Clin. Dermatol. 2009, 27:446-452.
6. EU, 2003. Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products, OJ L066, 11 March 2003, pp. 26-35.
7. Rogiers V., Pauwels M. Safety assessment of cosmetics in Europe. Curr. Probl. Dermatol. 2008, 36:17-20.
8. European Commission Consumer Affair Manual on the scope of application of the cosmetics directive 76/768/EEC (art. 1(1) cosmetics directive), June 2009.
9. J. Vernon, T. Nwaogu, A Comparative Study on Cosmetics Legislation in the EU and Other Principal Markets with Special Attention to so-called Borderline Products, August 2004, http://ec.europa.eu/enterprise/newsroom/cf/itemshortdetail.cfm%3Flang=it%26item_id=3519.
10. De Orsi D., Pellegrini M., Marchei E., Nebuloni P., Gallinella B., Scaravelli G., Martufi A., Gagliardi L. High performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of vardenafil, sildenafil, tadalafil, testosterone and local anesthetics in cosmetic creams sold on the Internet web sites. J. Pharm. Biomed. Anal. 2009, 50:362-369.
11. De Orsi D., Pellegrini M., Pichini S., Mattioli D., Marchei E., Gagliardi L. High-performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of non-allowed substances in cosmetic products for preventing hair loss and other hormone-dependent skin diseases. J. Pharm. Biomed. Anal. 2008, 48:641-648.
12. Gaudiano M.C., Lucente D., Antoniella E., Bertocchi P., Muleri N., Manna L., Bartolomei M., Alimonti M., Valvo L., Rodomonte A.L. For export only medicines come back to Europe: a RP-LC method for the screening of six glucocorticosteroids in illegal and counterfeit anti-inflammatory and lightening creams. J. Pharm. Biomed. Anal. 2010, 53:158-164.
13. Gagliardi L., De Orsi D., Chimenti P., Porrà R., Tonelli D. HPLC determination of imidazole antimycotis on antidandruff cosmetic products. Anal. Sci. 2003, 19:1195-1197.
14. Porra R., Berri S., Gagliardi L., Chimenti P., Granese A., De Orsi D., Carpani I., Tonelli D. Development of an HPLC method for the identification and dosage of non-allowed substances in cosmetic products. Part I. Local anaesthetics and antihistaminics. Anal. Bioanal. Chem. 2004, 380:767-772.
15. Maurer H.H. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin. Chem. Lab. Med. 2004, 42:1310-1324.
16. Wille S.M., Lambert W.E. Recent developments in extraction procedures relevant to analytical toxicology. Anal. Bioanal. Chem. 2007, 388:1381-1391.
17. Segura J., Ventura R., Jurado C. Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J. Chromatogr. B: Biomed. Sci. Appl. 1998, 713:61-90.